{"id":47190,"date":"2022-08-11T15:01:43","date_gmt":"2022-08-11T13:01:43","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-ophthalmic-viscoelastic-devices-market-report-2022-2030-featuring-carl-zeiss-stiftung-bausch-health-companies-johnson-johnson-alcon-rayner-intraocular-lenses-aurolab-researchandmarke\/"},"modified":"2022-08-11T15:01:43","modified_gmt":"2022-08-11T13:01:43","slug":"global-ophthalmic-viscoelastic-devices-market-report-2022-2030-featuring-carl-zeiss-stiftung-bausch-health-companies-johnson-johnson-alcon-rayner-intraocular-lenses-aurolab-researchandmarke","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-ophthalmic-viscoelastic-devices-market-report-2022-2030-featuring-carl-zeiss-stiftung-bausch-health-companies-johnson-johnson-alcon-rayner-intraocular-lenses-aurolab-researchandmarke\/","title":{"rendered":"Global Ophthalmic Viscoelastic Devices Market Report 2022-2030 Featuring Carl Zeiss Stiftung, Bausch Health Companies, Johnson & Johnson, Alcon, Rayner Intraocular Lenses, & Aurolab – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Viscoelastic Devices Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nOphthalmic Viscoelastic Devices Market Report is built to visualize quantitative market trends within Ophthalmic Devices therapeutic area.\n<\/p>\n

\nThe model discusses in detail the impact of COVID-19 on Ophthalmic Viscoelastic Devices (OVD) market for the year 2020 and beyond.\n<\/p>\n

\nOphthalmic viscoelastic devices, also known as OVDs, are devices used during intraocular surgery and are primary composed of sodium hyaluronate, chondroitin sulphate, or hydroxypropyl methylcellulose. These devices protect delicate ocular structures and reduce post operational complications such as corneal edema.\n<\/p>\n

\nOVDs help maintain pressure in the anterior chamber of the eyes and prevent iris prolapse by maintaining compartmentalization of the eyes. The use of these devices significantly reduces patient recovery times. They are often used in cataract surgeries, including extracapsular and phacoemulsification surgeries.\n<\/p>\n

\nOphthalmic Viscoelastic Devices (OVD) have a long history of use in the US and European markets and are well established in emerging markets such as APAC and South America.\n<\/p>\n

\nEach of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share\/rank analysis (wherever available).\n<\/p>\n

\nMoreover, analyst comments with qualitative insight offer context for quantitative data.\n<\/p>\n

\nDrive the understanding of the market by getting the veritable big picture including an overview of the healthcare system.<\/strong>\n<\/p>\n

\nIn addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.\n<\/p>\n